An endoscopy—using a fiber‐optic tube to peer inside the body and collect biopsy samples—can be an invaluable way to detect cancer of the esophagus. But sometimes, an endoscopy can miss esophageal cancer, which doesn’t get detected until weeks or months later.
YORK, S.C., Oct. 23, 2025 /PRNewswire/ — Elkem ASA (ticker: ELK), a global leader in advanced silicon-based materials, today unveiled SILBIONE™ LSR Select EC 70, a next-generation medical-grade liquid silicone rubber. Designed for wearable and diagnostic devices, the material combines high electrical conductivity, certified biocompatibility1, and enhanced process control, setting a new standard for precision healthcare applications.
Ypsomed announced that it launched YpsoLoop, its first autoinjector platform designed for circularity.
Olympus announced today that it launched Thunderbeat II, its next-generation hybrid energy device for soft tissue management.
Florida Atlantic University has expanded its NeuroInnovate Center, becoming the first institution globally to integrate advanced MRI and focused ultrasound technologies into a single, unified platform for both preclinical and clinical research. This breakthrough will accelerate the development of non-invasive treatments for neurological disorders such as Alzheimer’s, Parkinson’s and more.
NextBiomedical this week announced it enrolled the first patient in its U.S. pivotal clinical trial evaluating its Nexsphere-F, a fast-resorbable microsphere for embolization treatment of musculoskeletal pain.
https://www.medtechdive.com/news/stereotaxis-teams-with-cardiofocus-to-develop-robotic-pfa-system/802799/
How do eggs get Salmonella? This bacteria poses a real threat to many eggs, but can easily be killed by cooking at a high heat.
An Abbott (NYSE: ABT)+
official took to social media today to share that the company added Laralab to its portfolio of digital offerings.
ST. LOUIS, Oct. 9, 2025 /PRNewswire/ — Amplifi Vascular, developer of the first-of-its-kind Vein Dilation System designed to increase eligibility, improve creation and early maturation of arteriovenous fistulas (AVFs) for hemodialysis, today announced three major milestones: positive first-in-human (FIH) study results, the close of a $6.9 million Series A financing, and U.S. Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE).